Worth reading
25Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Who is moving to which position
Resolved 31 March 2026 (extraordinary general meeting of shareholders of 岩城製薬佐倉工場株式会社)Incoming appointee
1 itemScheduled Appointment DateEffective 1 April 2026. He is scheduled to assume the position of Representative Director and Chairman at 岩城製薬佐倉工場株式会社 at a meeting of its board of directors scheduled for 1 April 2026.
Iwaki Keitaro (岩城慶太郎)
Previous positionConcurrent position: Chairman of 岩城製薬佐倉工場株式会社
New positionConcurrent position: Representative Director and Chairman of 岩城製薬佐倉工場株式会社
Departing officer
1 itemIwaki Keitaro (岩城慶太郎)Next role stated
Former PositionConcurrent position: Chairman of 岩城製薬佐倉工場株式会社
New positionConcurrent position: Representative Director and Chairman of 岩城製薬佐倉工場株式会社
“Next role stated” means the document names the position the person holds after stepping down. It does not necessarily mean they are leaving the company.
Whether the incumbent will remain in office (whether they will retain their position)
Whether he will remain on the board: Not disclosed
Shareholders’ meeting approvalShareholder approval is required. The change was approved at an extraordinary general meeting of shareholders of 岩城製薬佐倉工場株式会社 held on 31 March 2026. Proposal name: Not disclosed
| Item | Details |
|---|---|
| Resolution date | 31 March 2026 (extraordinary general meeting of shareholders of 岩城製薬佐倉工場株式会社) |
| Scheduled Appointment Date | Effective 1 April 2026. He is scheduled to assume the position of Representative Director and Chairman at 岩城製薬佐倉工場株式会社 at a meeting of its board of directors scheduled for 1 April 2026. |
| Name of appointee | Iwaki Keitaro (岩城慶太郎) |
| Appointee's new position | Concurrent position: Representative Director and Chairman of 岩城製薬佐倉工場株式会社 |
| Appointee's previous position | Concurrent position: Chairman of 岩城製薬佐倉工場株式会社 |
| Name of departing officer | Iwaki Keitaro (岩城慶太郎) |
| Former position of departing officer | Concurrent position: Chairman of 岩城製薬佐倉工場株式会社 |
| New position of departing officer | Concurrent position: Representative Director and Chairman of 岩城製薬佐倉工場株式会社 |
| Whether the incumbent will remain in office | Whether he will remain on the board: Not disclosed |
| Subject to Approval by the General Meeting of Shareholders | Shareholder approval is required. The change was approved at an extraordinary general meeting of shareholders of 岩城製薬佐倉工場株式会社 held on 31 March 2026. Proposal name: Not disclosed |
Items this document does not state (11)
Date of departureAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeReason for departureReason for changeReasons for appointmentNumber of directors after the changeFiling as an independent officerDetails of organizational changesChange in Corporate Governance Structure
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company has not disclosed the specific reason for the change.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.